Spero Therapeutics, Inc. (SPRO)
2.605
-0.14
(-4.93%)
USD |
NASDAQ |
Jun 09, 13:36
Spero Therapeutics Price : 2.605 for June 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.10 |
| SELLAS Life Sciences Group, Inc. | 7.64 |
| ACADIA Pharmaceuticals, Inc. | 21.63 |
| Alnylam Pharmaceuticals, Inc. | 297.64 |
| Savara, Inc. | 4.875 |
Price Related Metrics
| PE Ratio | 10.69 |
| PS Ratio | 2.723 |
| Price to Book Value | 2.849 |
| Price to Free Cash Flow | 20.59 |
| Earnings Yield | 9.35% |
| Market Cap | 150.81M |
| Operating PE Ratio | 19.22 |
| Normalized PE Ratio | 10.34 |